Ever Source Wealth Advisors, LLC Nuvalent, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 24 shares of NUVL stock, worth $1,907. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24
Previous 21
14.29%
Holding current value
$1,907
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NUVL
# of Institutions
231Shares Held
58.9MCall Options Held
834KPut Options Held
490K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.43 Billion34.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.36MShares$426 Million16.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$240 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.62MShares$208 Million6.84% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.42B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...